Phone vs. mail: which gets more people to screen for type 1 diabetes?

NCT ID NCT07663136

Not yet recruiting Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two ways of inviting people to screen for type 1 diabetes at home: a simple email or letter versus a personal phone call. Researchers want to see which method leads more people to complete and return a home screening kit. Participants are adults and children aged 1 to 99 who are already part of the Indiana Biobank.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If one recruitment method proves far more effective, future screening programs could use that approach to identify more people at risk for type 1 diabetes earlier.
What could go wrong: This trial only measures how many people return a screening kit, not whether screening improves health outcomes. The results may not apply to populations outside the Indiana Biobank.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULT TYPE 1 DIABETES (T1D)

Contacts and locations

Locations

Indiana University School of Medicine

Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.